BioNTech CEO confident of quickly adapting vaccine for Omicron

BioNTech should be able to adapt its Covid vaccine relatively quickly in response to Omicron variant, its CEO said. BioNTech and Pfizer Inc together produced one of the first vaccines against Covid-19, with well over 2 billion doses already given to protect people around the world. There are concerns that the vaccines might not work as well against the Omicron variant which emerged last month.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.